UBS has recently raised Hanesbrands Inc. (HBI) stock to Buy rating, as announced on November 26, 2024, according to Finviz. Earlier, on November 10, 2022, Credit Suisse had reduced the stock from a ...

Verve Therapeutics Inc (VERV) stock saw a decline, ending the day at $7.91 which represents a decrease of $-0.08 or -1.00% from the prior close of $7.99. The stock opened at $7.99 and touched a low of ...

Celsius can recover when the economy is stronger, but the timing is difficult to predict. The global energy drink market is ...

Three parties are holding their delegates' meetings this Saturday. The SVP Switzerland wants to rally its party base to fight ...

Wind conditions made flights impossible on the first day of the International Balloon Festival in Château-d'Oex in canton ...